Sunimaps 12.5mg Capsule is a medication containing the active ingredient sunitinib, a tyrosine kinase inhibitor. It works by blocking the action of certain proteins that help cancer cells grow and divide. This disruption can slow down or stop the growth of cancer cells and may also help to shrink tumors.
Sunimaps is primarily indicated for the treatment of certain types of cancer, including advanced renal cell carcinoma (kidney cancer), advanced gastrointestinal stromal tumor (GIST) after failure of prior treatment, and advanced pancreatic neuroendocrine tumors (pNET) in patients with progressive disease. It is typically prescribed by an oncologist and the dosage and duration of treatment are determined by the patient’s specific condition and response to therapy.
Common side effects may include fatigue, diarrhea, nausea, vomiting, hypertension, skin discoloration, and changes in hair color. It is important to discuss any potential side effects with your healthcare provider. Sunimaps should be stored at room temperature, away from moisture and heat. Keep out of reach of children.
